Combining allogeneic immunotherapy with an mTOR inhibitor for advanced renal cell carcinoma

被引：0
|
作者：
S S Tykodi
L N Voong
E H Warren
机构：
[1] Fred Hutchinson Cancer Research Center,Clinical Research Division
[2] University of Washington,Department of Medicine, Division of Medical Oncology
来源：
Bone Marrow Transplantation | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1360 / 1362
页数：2
相关论文
共 50 条
  • [1] Combining allogeneic immunotherapy with an mTOR inhibitor for advanced renal cell carcinoma
    Tykodi, S. S.
    Voong, L. N.
    Warren, E. H.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 (08) : 1360 - 1362
  • [2] Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma
    Malizzia, Lois J.
    Hsu, Arlene
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2008, 12 (04) : 639 - 646
  • [3] Immunotherapy for advanced renal cell carcinoma
    Aulitzky, WE
    Kaufmann, M
    [J]. UROLOGE A, 2004, 43 (01): : 85 - 92
  • [4] mTOR Inhibitors in Advanced Renal Cell Carcinoma
    Voss, Martin H.
    Molina, Ana M.
    Motzer, Robert J.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (04) : 835 - +
  • [5] Emerging immunotherapy in advanced renal cell carcinoma
    Mendiratta, Prateek
    Rini, Brian I.
    Ornstein, Moshe C.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (12) : 687 - 693
  • [6] IMMUNOTHERAPY OF ADVANCED RENAL-CELL CARCINOMA
    BERGMANN, L
    WEIDMANN, E
    MITROU, PS
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1991, 116 (10) : 384 - 390
  • [7] Combined immunotherapy for advanced renal cell carcinoma
    Maejima, Aiko
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S416 - S416
  • [8] The role of immunotherapy in advanced renal cell carcinoma
    Mondlane, Ercilia Rita
    Abreu-Mendes, Pedro
    Martins, Diana
    Cruz, Rui
    Mendes, Fernando
    [J]. INTERNATIONAL BRAZ J UROL, 2021, 47 (06): : 1228 - 1242
  • [9] Adjuvant immunotherapy for locally advanced renal cell carcinoma
    Alevizakos, Michail
    Mcdermott, David
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (12) : 1265 - 1275
  • [10] Therapeutic Rationale for mTOR Inhibition in Advanced Renal Cell Carcinoma
    Husseinzadeh, Holleh D.
    Garcia, Jorge A.
    [J]. CURRENT CLINICAL PHARMACOLOGY, 2011, 6 (03): : 214 - 221
12345